Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for NYSE:IMA
35.45
+0.05 (0.14%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 35.10 - 35.56
52 week 30.14 - 40.80
Open 35.54
Vol / Avg. 171,190.00/641,957.00
Mkt cap 2.95B
P/E     -
Div/yield     -
EPS -1.22
Shares 83.09M
Beta 2.02
Inst. own 91%
Oct 27, 2014
Q3 2014 Alere Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 21, 2014
Alere Inc Annual Shareholders Meeting
Aug 13, 2014
Alere Inc at Canaccord Genuity Growth Conference
Aug 4, 2014
Q2 2014 Alere Inc Earnings Release
Aug 4, 2014
Q2 2014 Alere Inc Earnings Call
Jun 24, 2014
Alere Inc at JMP Securities Healthcare Conference
Jun 11, 2014
Alere Inc at Goldman Sachs Healthcare Conference
Jun 4, 2014
Alere Inc at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -7.00% -2.90%
Operating margin -1.19% 4.44%
EBITD margin - 20.13%
Return on average assets -2.96% -1.24%
Return on average equity -15.07% -6.08%
Employees 17,600 -
CDP Score - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�s segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Officers and directors

Namal Nawana Interim President and Chief Executive Officer, Chief Operating Officer
Age: 43
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Daniella Cramp Global President - cardiometabolic business unit
Age: 40
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President - Alere International Limited
Age: 50
Bio & Compensation  - Reuters
Craig Keyes M.D. Global President - Alere Health Information Solutions
Age: 58
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 44
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 65
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 67
Bio & Compensation  - Reuters
Carla Flakne Chief Accounting Officer, Vice President
Age: 60
Bio & Compensation  - Reuters